The largest database of trusted experimental protocols

Ultimate 3000 sd hplc system

Manufactured by Thermo Fisher Scientific
Sourced in United States, Netherlands

The UltiMate 3000 SD HPLC system is a high-performance liquid chromatography instrument designed for versatile analytical applications. It features a modular design, advanced control software, and precision components to deliver reliable and reproducible separation of a wide range of analytes.

Automatically generated - may contain errors

3 protocols using ultimate 3000 sd hplc system

1

HPLC Analysis of Metabolite Products

Check if the same lab product or an alternative is used in the 5 most similar protocols
The stored reaction mixture solutions or fermentation extracts were subjected to HPLC analysis (Dionex UltiMate 3000 SD HPLC system, Thermo Scientific, MA, USA). The separation was achieved on a C18 column (SilGreen ODS column [φ 4.6 × 250 mm, S-5 μM], Greenherbs, Beijing, China) with a flow rate of 1 ml/min at 40°C. A linear gradient elution was performed with mobile phases containing acetonitrile (A) and H2O (B). For detection of the product of K19G: 0 min: 40% A in 60% B; 0–10 min: linear gradient increase to 80% A in 20% B; 10–15 min: 100% A; 15–16 min: 40% A in 60% B; 16–20 min: 40% A in 60% B. For detection of the product of S19G, Sm: 0 min: 20% A in 80% B; 0–10 min: gradient increased to 60% A in 40% B; 10–15 min: 100% A; 15–16 min: 20% A in 80% B; 16–20 min: 20% A in 80% B. For detection of the product of Sb, Rub: 0 min: 15% A in 85% B; 0–10 min: line gradient increase to 55% A in 45% B; 10–15 min: 100% A; 15–16 min: 15% A in 85% B; 16–20 min: 15% A in 85% B. For detection of the product of stevioside, RedA, RedD: 0 min: 5% A in 95% B; 0–10 min: line gradient increase to 45% A in 55% B; 10–15 min: 100% A; 15–16 min: 5% A in 95% B; 16–20 min: 5% A in 95% B.
+ Open protocol
+ Expand
2

UPLC Separation of Fluorescently Labeled Glycans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescently labeled glycans were separated
on an Acquity UPLC glycan BEH amide column (2.1 × 100 mm, 1.7
μm, Waters Chromatography BV, Etten-Leur, Netherlands), using
an UltiMate 3000 SD HPLC system (Thermo Fisher Scientific, Waltham,
MA, U.S.A.) equipped with a Jasco FP-920 fluorescence detector (λex, 330 nm; λem, 420 nm; Jasco, Inc., Easton,
MD, U.S.A.). An injection volume of 3 μL was used. Ternary gradients
were run using Milli-Q water, acetonitrile, and a buffer solution
consisting of 250 mM formic acid in Milli-Q water, adjusted to pH
3.0 using ammonia. A constant 20% of the buffer was maintained throughout
the run. Elution was performed by a slow sloping gradient of 22–40%
Milli-Q water (total concentration, including buffer) from 0 to 67.5
min. The remaining percentage of the solvent composition comprised
of acetonitrile. After completion of the gradient, final gradient
conditions were maintained for 9 min and the column reconditioned
back to initial conditions for 13 min.
+ Open protocol
+ Expand
3

Plasma Catechols Quantification by HPLC-ED

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were thawed on ice and a spatula-tip (~5mg) of activated alumina powder (199966, Sigma) was added to each well of a 96-well AcroPrep filter plate with 0•2 µM wwPTFE membrane (514-1096, VWR). A100 µL of plasma sample, 1 µM DHBA (3,4-dihydroxybenzylamine hydrobromide, 858781, Sigma) as an internal standard, and 800 µL of TE buffer (2•5% EDTA; 1•5 M Tris/HCl pH 8•6) were added sequentially to the wells. Liquid was removed using a 96-well plate vacuum manifold and the alumina were washed twice with 800 µl of H2O. Catechols were eluted using 0•7% HClO4, which was incubated for 30 min at RT. Samples were injected in a HPLC-ED system (Ultimate 3000 SD HPLC system coupled to Ultimate 3000 ECD-3000RS electrochemical detector with a glassy carbon working electrode (DC amperometry at 800 mV), Thermo Scientific). Samples were analysed on a C18 column (Kinetex 5 μM, C18 100 Å, 250 × 4•6 mm, Phenomenex, Utrecht, The Netherlands) using a gradient of water/methanol with 0•1% formic acid (0-3 min, 99% H2O; 3-7 min, 99-30% H2O; 7-10 min 30-5% H2O; 10-11 min 5% H2O; 11-18 min, 99% H2O). Data recording and analysis were performed using Chromeleon software (version 6•8 SR13). Potential intake differences of levodopa were corrected by using carbidopa as an internal standard.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!